By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
TrovaGene, Inc. To Present Clinical Data And Capabilities Of Its Urine-Based Liquid Biopsy Platform At The 7th Annual Next Generation Dx Summit 8/18/2015 6:46:23 AM
TrovaGene, Inc. Announces Second Quarter 2015 Financial Results 8/11/2015 10:05:32 AM
TrovaGene, Inc. Schedules Release Of Second Quarter 2015 Financial Results And Investor Conference Call 7/23/2015 11:59:50 AM
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 7/22/2015 10:07:40 AM
TrovaGene, Inc. Announces Public Offering Of Common Stock 7/17/2015 6:36:04 AM
TrovaGene, Inc. Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 7/8/2015 6:39:30 AM
TrovaGene, Inc. To Present At Cantor Fitzgerald's Inaugural Healthcare Conference 7/7/2015 7:47:58 AM
TrovaGene, Inc. Upgraded To Russell 3000, Small Cap And Global Indexes 6/29/2015 7:06:23 AM
Clinical Data Featuring TrovaGene, Inc.'s Urine-Based Liquid Biopsy Platform To Be Presented At Two Upcoming Medical Conferences 6/8/2015 10:05:03 AM
TrovaGene, Inc. Launches Commercial Marketing Campaign At The 2015 ASCO Annual Meeting 5/28/2015 7:50:42 AM